Tag

Tag: Forbion Capital Partners

Inflazome Forbion anti-inflammatory macrophage

19/11/2018 2 mins

Anti-Inflammatory Treatments Get €40M Boost in Series B

01/10/2018 2 mins

Update: Forbion’s Life Science Fund Tops Goal by €90M

Lung Diseases

12/04/2018 1 min

British Biotech Raises £29M Round to Fight Lung Disease

escalier-biosciences-psoriasis

15/03/2018 1 min

Dutch Biotech Raises $19M to Treat Psoriasis Without Injections

12/12/2017 2 mins

New Dutch Biotech Sails Straight into Phase II with €25M Series A to Treat NASH

20/06/2017 2 mins

“We’re at a second revolution in cancer therapy” – Experts discuss the Future of Oncology at Refresh

sander_van_deventer_forbion

08/05/2017 4 mins

Meet the co-developer of the first commercial mAb and gene therapy

28/03/2017 5 mins

Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?

07/02/2017 2 mins

Swiss Parkinson’s Biotech raises Massive €29M in Series B from Top European VCs

07/02/2017 9 mins

Not to be Underestimated: What’s the Hype around NASH?

Europe_VC_top_investors_biotech_life_sciences_finance

12/04/2016 10 mins

18 of the Best European VCs for Biotech in 2016

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.